Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-04

Clinical Trial Update: Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessed the efficacy and safety of pregabalin for treating neuropathic pain in patients with idiopathic small fiber neuropathy; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Idiopathic Small Fiber Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2018-10-04